Literature DB >> 18286388

Physical activity and neuroprotection in amyotrophic lateral sclerosis.

Mary E McCrate1, Brian K Kaspar.   

Abstract

Physical exercise exerts a wide range of benefits on an organism's overall health and well-being. Exercise contributes positively toward an individual's healthy weight, muscle strength, immune system, and cardiovascular health. Indeed, exercise has been demonstrated to reduce life-threatening conditions such as high blood pressure, heart disease, obesity, and diabetes. Of particular interest to this review, exercise has also been shown to be neuroprotective in both the central and peripheral nervous systems. Naturally, such findings apply broadly to the study of neurodegenerative disease with numerous reports demonstrating that exercise has beneficial effects on disease progression. One of the most devastating neurodegenerative diseases is amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease in the United States, or motor neuron disease in the United Kingdom, resulting from the progressive loss of brain and spinal cord motor neurons. Several human studies show that moderate exercise regimens improve ALS patients' scoring on functionality tests and ameliorate disease symptoms. Other promising recent works using transgenic mouse models of familial ALS have shown markedly slowed disease progression, improved function, and extension of survival in moderately exercised animals. Possible explanations for these findings include the exercise-induced changes in motor neuron morphology, muscle-nerve interaction, glial activation, and altering levels of gene expression of anti-apoptotic proteins and neurotrophic factors in the active tissue. Here we review the current literature on exercise and motor neuron disease, focusing on rodent and human studies to define the proper type, intensity, and duration of exercise necessary to enhance neuron survival as well discuss current mechanistic studies to further define the exercise-mediated pathways of neuroprotection.

Entities:  

Mesh:

Year:  2008        PMID: 18286388     DOI: 10.1007/s12017-008-8030-5

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  81 in total

1.  A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III).

Authors: 
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

Review 2.  Sports and trauma in amyotrophic lateral sclerosis revisited.

Authors:  Carmel Armon
Journal:  J Neurol Sci       Date:  2007-08-02       Impact factor: 3.181

3.  Fast axonal transport of labeled proteins in motoneurons of exercise-trained rats.

Authors:  B J Jasmin; P A Lavoie; P F Gardiner
Journal:  Am J Physiol       Date:  1988-12

4.  Prevention of spinal motor neuron death by insulin-like growth factor-1 associating with the signal transduction systems in SODG93A transgenic mice.

Authors:  Hisashi Narai; Isao Nagano; Hristeina Ilieva; Mito Shiote; Tetsuya Nagata; Takeshi Hayashi; Mikio Shoji; Koji Abe
Journal:  J Neurosci Res       Date:  2005-11-15       Impact factor: 4.164

5.  Extensive exercise is not harmful in amyotrophic lateral sclerosis.

Authors:  David Liebetanz; Katrin Hagemann; Friederike von Lewinski; Elke Kahler; Walter Paulus
Journal:  Eur J Neurosci       Date:  2004-12       Impact factor: 3.386

6.  Amyotrophic lateral sclerosis. A study of its presentation and prognosis.

Authors:  S S Gubbay; E Kahana; N Zilber; G Cooper; S Pintov; Y Leibowitz
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

7.  Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.

Authors:  M E Ripps; G W Huntley; P R Hof; J H Morrison; J W Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

Review 8.  Exercise: a behavioral intervention to enhance brain health and plasticity.

Authors:  Carl W Cotman; Nicole C Berchtold
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

9.  Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase.

Authors:  H Ischiropoulos; L Zhu; J Chen; M Tsai; J C Martin; C D Smith; J S Beckman
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

10.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.

Authors:  Mimoun Azzouz; G Scott Ralph; Erik Storkebaum; Lucy E Walmsley; Kyriacos A Mitrophanous; Susan M Kingsman; Peter Carmeliet; Nicholas D Mazarakis
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

View more
  13 in total

1.  Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study.

Authors:  Ettore Beghi; Giancarlo Logroscino; Adriano Chiò; Orla Hardiman; Andrea Millul; Douglas Mitchell; Robert Swingler; Bryan J Traynor
Journal:  Amyotroph Lateral Scler       Date:  2010-05-03

2.  Aerobic exercise protects retinal function and structure from light-induced retinal degeneration.

Authors:  Eric C Lawson; Moon K Han; Jana T Sellers; Micah A Chrenek; Adam Hanif; Marissa A Gogniat; Jeffrey H Boatright; Machelle T Pardue
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

3.  Peripheral hyperstimulation alters site of disease onset and course in SOD1 rats.

Authors:  Angelo C Lepore; Christopher Tolmie; John O'Donnell; Megan C Wright; Christine Dejea; Britta Rauck; Ahmet Hoke; Anthony R Ignagni; Raymond P Onders; Nicholas J Maragakis
Journal:  Neurobiol Dis       Date:  2010-04-08       Impact factor: 5.996

4.  TrkB signalling pathway mediates the protective effects of exercise in the diabetic rat retina.

Authors:  Rachael S Allen; Adam M Hanif; Marissa A Gogniat; Brian C Prall; Raza Haider; Moe H Aung; Megan C Prunty; Lukas M Mees; Monica M Coulter; Cara T Motz; Jeffrey H Boatright; Machelle T Pardue
Journal:  Eur J Neurosci       Date:  2018-04-03       Impact factor: 3.386

5.  Moderate exercise delays the motor performance decline in a transgenic model of ALS.

Authors:  Isabel Carreras; Sinan Yuruker; Nurgul Aytan; Lokman Hossain; Ji-Kyung Choi; Bruce G Jenkins; Neil W Kowall; Alpaslan Dedeoglu
Journal:  Brain Res       Date:  2009-12-05       Impact factor: 3.252

Review 6.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

7.  Novel mechanistic insights into treadmill exercise based rescue of social defeat-induced anxiety-like behavior and memory impairment in rats.

Authors:  Gaurav Patki; Naimesh Solanki; Fatin Atrooz; Amber Ansari; Farida Allam; Brittany Jannise; Jaganmohan Maturi; Samina Salim
Journal:  Physiol Behav       Date:  2014-04-13

8.  Shifting Tides Toward a Proactive Patient-Centered Approach in Dysphagia Management of Neurodegenerative Disease.

Authors:  Nicole M Rogus-Pulia; Emily K Plowman
Journal:  Am J Speech Lang Pathol       Date:  2020-07-10       Impact factor: 2.408

9.  Different human copper-zinc superoxide dismutase mutants, SOD1G93A and SOD1H46R, exert distinct harmful effects on gross phenotype in mice.

Authors:  Lei Pan; Yasuhiro Yoshii; Asako Otomo; Haruko Ogawa; Yasuo Iwasaki; Hui-Fang Shang; Shinji Hadano
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

10.  Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study.

Authors:  Valentina Gallo; Nicola Vanacore; H Bas Bueno-de-Mesquita; Roel Vermeulen; Carol Brayne; Neil Pearce; Petra A Wark; Heather A Ward; Pietro Ferrari; Mazda Jenab; Peter M Andersen; Patrik Wennberg; Nicholas Wareham; Verena Katzke; Rudolf Kaaks; Elisabete Weiderpass; Petra H Peeters; Amalia Mattiello; Valeria Pala; Aurelio Barricante; Maria-Dolores Chirlaque; Noémie Travier; Ruth C Travis; Maria-Jose Sanchez; Hélène Pessah-Rasmussen; Jesper Petersson; Anne Tjønneland; Rosario Tumino; Jose Ramon Quiros; Antonia Trichopoulou; Andreas Kyrozis; Despoina Oikonomidou; Giovanna Masala; Carlotta Sacerdote; Larraitz Arriola; Heiner Boeing; Matthaeus Vigl; Francoise Claver-Chapelon; Lefkos Middleton; Elio Riboli; Paolo Vineis
Journal:  Eur J Epidemiol       Date:  2016-03-11       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.